login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Non-surgical cryoplasty therapy may save legs, early research suggests


Tuesday, 03 May 2005 00:00
James Joye
James Joye

According to preliminary data on 22 patients being presented at the 17th Annual International Symposium on Endovascular Therapy (ISET), all patients who were facing almost-certain amputation were successfully treated with a new non-surgical therapy that gently cools and opens leg arteries clogged with plaque. CryoPlasty therapy treats patients with arteries that are blocked below the knee as a result of peripheral arterial disease (PAD).
CryoPlasty therapy fits into the treatment spectrum before the use of angioplasty and appears to lessen some of the complications seen in that procedure. It also can be used to treat other vessels affected by PAD, including arteries in the thighs and abdomen.
"Previously, amputation was the only option for some people with such advanced disease in arteries below the knee, many of whom are diabetic," said Dr James D Joye, director of the Cardiac Catheterization Lab at El Camino Hospital, Mountain View, Calif., and co-inventor of the CryoPlasty technique. "CryoPlasty is a 'no-harm' treatment that offers early, conservative management and can be used repeatedly - not only avoiding or delaying amputation, but postponing the use of more invasive procedures."
The data on 22 patients presented at ISET by Joye are the first results from 'Below the Knee Chill', an ongoing multi-center study at 30 hospitals across the US, which will enroll 100 patients who are likely facing amputation of a foot or leg within six months. All of the patients in the study have critical limb ischemia, meaning they have severely clogged leg arteries, causing extremely poor blood flow. Treatment in all 22 patients resulted in procedural success, meaning artery blockages (stenoses) were 50% or less after CryoPlasty therapy. After treatment, the average blockage was 19%, compared to 87% before treatment. Immediately after the procedure, ankle or toe pulses improved in 17 of 20 patients (85%), meaning blood flow increased. Pulses were not measured in two patients. There were no procedural complications or adverse events. Follow-up is ongoing.
Other data, on 102 patients who received CryoPlasty therapy to treat blocked upper leg or knee arteries, have shown that 83% of the arteries remained opened after nine months. An estimated 60% of blocked blood vessels treated with traditional angioplasty and/or stenting remain open after one year, with 89% of people reported an improvement in leg pain while walking.
In a separate single-center study, 51 people received CryoPlasty therapy for 64 blockages, the majority in the thighs, abdomen or lower legs and follow up ranged from three months to one year. After CryoPlasty therapy, only two of the blockages (3%) required placement of a stent. Placement of a stent after traditional angioplasty has been reported as high as 80% and a majority of the time multiple stents are required. A total of 53% of the patients had critical limb ischemia (CLI), meaning their lower leg arteries were so severely blocked, that they suffered pain in their legs and were at risk of amputation of a foot or leg. To date none of the patients have required amputation. Thirteen (48%) of the CLI patients have been followed for six months, and 11 (86%) say their leg pain has improved dramatically.
After CryoPlasty therapy, the overall rate of dissection was 8%, which compares favourably to the dissection rate for angioplasty which ranges from 40% to 70%. CryoPlasty therapy involves the use of nitrous oxide, rather than saline, to inflate the balloon and cool it to
-10°C. This in turn prompts several physical responses that open the artery and cause less scarring than occurs with traditional angioplasty. Repeat procedures for patients treated with standard balloon angioplasty and stent technology of the arteries below the knee are reported to be as high as 85%. The below-the-knee CryoPlasty procedure is performed using one of several new smaller sized catheters, which received clearance from the FDA.
The PolarCath System is a proprietary technology for delivering the CryoPlasty therapy developed by CryoVascular Systems, who has a strategic partnership with Boston Scientific Corporation.



Most popular


First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

New deep vein thrombosis guidelines: What you need to know
Thursday, 23 Oct 2014
Suresh Vedantham spoke to Interventional News on the latest from the paper “Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus ... New deep vein thrombosis guidelines: What you need to know

Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years
Wednesday, 19 Nov 2014
Three-year follow-up results of patients treated with the Supera stent show that nominal deployment or slight compression of the device delivers the best outcomes in terms of durability, and that ... Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years

Features


Selective transarterial chemo embolization in lung cancer
Wednesday, 19 Nov 2014
Embolization therapy combined with infusion of antineoplastic agents offers considerable improvement of symptoms for patients, with far fewer complications than systemic chemotherapy, writes Shinichi ... Selective transarterial chemo embolization in lung cancer

Multidisciplinary panel recommends early revascularisation of diabetic foot to save legs
Tuesday, 04 Nov 2014
Delays in revascularisation of diabetic foot in the UK directly relate to legs being lost to amputation. Early referral to interventionists is of critical importance and interventional radiologists ... Multidisciplinary panel recommends early revascularisation of diabetic foot to save legs

Profiles


José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions